2021 SUMMIT

Oct 25-27, 2021

Nashville, TN

AN ACTION-ORIENTED SUMMIT ON THE DATA AND DIGITAL INFRASTRUCTURE PRECISION MEDICINE NEEDS TO THRIVE

Stakeholders across the healthcare system face significant barriers to the effective implementation of precision medicine.

Solutions must carefully consider the practical realities of a complex, multi-stakeholder environment.

This Summit provides influential leaders a candid, collaborative forum to define and implement solutions that connect the genetic health information network.

An intimate meeting of influential leaders from across in the Genetic Health Information Network

Representing all stakeholders in this ecosystem, including

Health plans
Clinicians
Hospital systems
Researchers
Policy makers

Patients & Advocates
Laboratories
IT Vendors
Pharma

2019 Organizing Committee

2021 Organizers – Coming Soon

PRISCILLA ALFARO, MD

Chief Medical Officer

Zelis

DAWN BARRY

Co-Founder & President

LunaDNA

Kristine Bordenave, MD

Corporate Medical Director

Humana

Carlos Bustamante, PhD

Venture Partner

F-Prime Capital

JOSHUA DENNY, MD

Professor of Biomedical Informatics and Medicine

Vanderbilt University

Henry Garlich

Director, Healthcare Value Solutions & Enhanced Clinical Programs

Blue Shield of California

Trent Haywood, MD, JD

SVP & Chief Medical Officer

Blue Cross Blue Shield Association

Gillian Hooker, PhD, ScM, LCGC

VP, Clinical Development

Concert Genetics

JIM JIRJIS, MD

Chief Health Information Officer

HCA Healthcare

HOWARD LEVY, MD, PHD

Associate Professor of Medicine

Johns Hopkins Medicine

LAURIE MCGRAW

SVP, Health Solutions

American Medical Association

NICK NACLERIO

Founding Partner

Illumina Ventures

ROBERT NUSSBAUM, MD

Chief Medical Officer

Invitae

BRYCE OLSON

Global Marketing Director, Health & Life Sciences

Intel Corp.

JULIE RAMAGE

National Accounts Director, Diagnostics

Pfizer

SHUVAYU SEN, PHD

Executive Director, Center for Observational & Real-World Evidence

Merck

BENJAMIN SOLOMON, MD

Managing Director

GeneDx

The only multi-stakeholder gathering focused on solving the data, digital infrastructure, and economic challenges facing precision medicine

Intimate, carefully curated, invitation-only gathering

Full spectrum of stakeholders

Focused on needs and solutions

Collaborative, discussion-oriented format

Chatham-house rules — non-attribution

No sponsored talks, sales pitches or marketing lists

Published conference summary and recommendations

Identify and resolve practical barriers facing precision medicine by

Improving the capture of clinical effectiveness and economic value data
Simplifying the test ordering and resulting workflow for clinicians, hospitals and labs
Streamlining the genetic test billing, adjudication and payment process
Reducing the frequency of misordered tests and surprise bills for patients
Empowering patients to harness the insights in their genetic makeup for greater health

2019 Speakers & Panelists

Click here for 2019 working agenda and session descriptions

2021 Speakers – Coming Soon

Jim Jirjis, MD

Chief Health Information Officer

HCA Healthcare

Esteban López, MD

Chief Medical Officer, Clinical Strategy Innovation

Health Care Service Corporation
BCBS of IL, MT, NM, OK & TX

Kate Donigan, PhD

Deputy Director, Personalized Medicine & Molecular Genetics (acting)

U.S. Food and Drug Administration (FDA)

Shuvayu Sen, PhD

Executive Director,
Center for Observational & Real-World Evidence

MERCK

Vincent Nelson, MD

VP, Medical Affairs

Blue Cross Blue Shield Association

Mira Irons, MD

Chief Health & Sciences Officer

American Medical Association (AMA)

Margaret Anderson

Managing Director

Deloitte Consulting

Priscilla Alfaro, MD

Chief Medical Officer

Zelis

Kenneth Mandl, MD, MPH

Professor & Director, Computational Health Informatics Program (CHIP)

Harvard Medical School & Boston Children’s Hospital

Stephanie Devaney, PhD

Deputy Director,
All of Us

National Institutes of Health (NIH)

Steven Goldberg, MD

VP, Medical Affairs, Population Health &
Chief Health Officer

Quest Diagnostics

Trish Brown, MS, CGC

Director, Americas Payer Partner & Field Market Access Lead

Illumina

Kate Black

Shareholder, Data, Privacy & Cybersecurity Group

Greenberg Traurig

Victor Wu, MD, MPH

Chief Medical Officer

TennCare

James Lu, MD, PhD

Co-founder & SVP,
Applied Genomics

Helix

Jessica Zeaske

Partner

Echo Health Ventures

Hunt Willard, PhD

Director & Principal

Geisinger National

Lisa Alderson

Co-founder & CEO

Genome Medical

Stephen Knight, MD

President & Managing Partner

F-Prime Capital

Nick Naclerio, PhD

Founding Partner

Illumina Ventures

James Hazel, PhD, JD

Research Fellow, Center for Genetic Privacy and Identity in Community Settings (GetPreCiSe)

Vanderbilt University Medical Center

Terry Jo Bichell, PhD

Rare Disease Biomarkers & Outcomes Measurement Consultant

+78 Net Promoter Score

This Summit is back by popular demand thanks to the enthusiastic response of last year’s participants.

“Intimate engagement with key stakeholders in the genomic medicine space that does not otherwise happen all that often…Excellent and efficient organization and moderation with summary of key points throughout.”

Director, Molecular Pathology

“Excellent speakers, panels, participants, and facilitation on relevant topics”

CEO, genomics company

“It was a unique and diverse group of stakeholders with (most importantly) time to interact with each other. Key gaps that need to be bridged were openly discussed and at least understood, if not resolved.”

Chief Medical Officer

“I thought that the summit raised important issues and brought together interested and diverse individuals to exchange ideas and propose serious solutions to real problems in the field.”

President, advocacy organization

“Open discussion, and a focus on actionable takeaways. Attendance by people who are influential.”

Director, Science Policy



This event is by invitation only. If you would like to nominate somebody, including yourself, to participate in the summit, please complete the following form: